Hormone Health Screen

We are one of the few practices in the UK to offer such a comprehensive hormone screen. Uniquely, our analysis covers a total of 18 different hormones in the blood and includes thorough female hormone profiling. The results are measured and we undertake thorough investigation of readings both outside the acceptable scale and those within the scale that are relatively low or high. The screening programme provides a thorough hormonal analysis including thyroid, growth hormone, testosterone, oestrone, luteinizing hormone, follicle-stimulating hormone and progesterone - it is particularly useful for identifying anaemia and thyroid problems. Treatment programmes are individualised to each patient and normally tend to be the combination of homeopathic preparations of either oestrogen, progesterone, testosterone, thyroxine, melatonin, serotonin, insulin, coupled with classical homeopathic preparations such as sanguinaria, secale, sepia, pulsatilla, cimicifuga, to name but a few. These combinations are in accord with the principles of complex homeopathy as developed in Germany. These remedies are energetic in their action and have the effect of steering the body’s own resources to correct hormonal imbalance.

The pharmaceutical approach to hormonal rebalancing is through the effects of herbal compositions, mostly of Chinese herbs tending to be in either capsule or tablet form containing concentrated extracts of herbs. The clinic has available over fifty different compositions covering a wide variety of hormonal imbalances such as PMT, menopause, endometriosis, ovarian cystic syndrome, heavy periods, painful periods, infertility, habitual miscarriage, general blood deficiency, fatigue, low libido, and scanty irregular periods. These compositions, although treating hormonal imbalance, are holistic in their treatment effect because of the holistic approach in diagnosis.

Other related test procedures and subsequent treatments associated with hormonal imbalances may include, chiropractic assessment of back and pelvis, as through the German chiropractic technique of meridian balancing through chiropractic; allergy and food sensitivity evaluation; amino-acid, fatty acid and bio-mineral profiles.  Subsequently, the practitioner will work out an appropriate and individual treatment programme.

Anti-Mullerian Hormones (AMH)

Measurement of ovarian reserve is of interest to women in general, and assessment of ovarian reserve may provide insight into the remaining number of fertile years a woman has.  The Anti-Mullerian Hormone (AMH) is an endocrine marker for quantitive prediction of ovarian reserve, ovarian aging, ovarian dysfunction and ovarian responsiveness.

In instances of Polycystic Ovary Syndrome (PCOS), a well-recognised endocrine disorder in women of reproductive age, a two or three fold increase in growing follicles would be reflected in a two or three fold increase in blood AMH levels.  The Anti-Mullerian Hormone test can therefore be beneficial in the diagnosis of PCOS and as a marker for the patient’s response to treatment.

Evaluating Fertility Potential

Blood AMH levels correlate with the number of antral follicles with great specificity than inhibit B, Oestradiol, Follicle Stimulating Hormone and Luteinizing Hormone on day 3 of the cycle.  Therefore, day 3 AMH levels may reflect ovarian status better than the usual hormone markers mentioned.

Measuring Ovarian Aging

Diminished ovarian reserve, associated with poor response to in vitro fertilization, is signalled by reduced baseline serum AMH concentrations.  AMH would appear to be a useful marker for predicting ovarian aging and the potential for successful IVF.

Predicting Onset of Menopause

The duration of the menopausal transition can vary significantly in individual women, and reproductive capacity may be compromised before hormonal imbalances are evident.  AMH levels can predict the occurrence of the menopausal transition.

Assessing Polycystic Ovary Syndrome (PCOS)

Blood AMH levels are elevated in patients with Polycystic Ovary Syndrome and may be useful as a marker for the extent of the disease and the progress of treatment.